These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 3111722

  • 21. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O, Shimizu M, Saeki Y, Kishimoto S, Kishimoto T.
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [Abstract] [Full Text] [Related]

  • 22. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ, Muraguchi A, Hong JX, Butler JL, Dinarello CA, Fauci AS.
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [Abstract] [Full Text] [Related]

  • 23. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.
    Richard Y, Leprince C, Dugas B, Treton D, Galanaud P.
    J Immunol; 1987 Sep 01; 139(5):1563-7. PubMed ID: 3114370
    [Abstract] [Full Text] [Related]

  • 24. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH, Vitetta ES.
    J Immunol; 1986 Nov 15; 137(10):3205-10. PubMed ID: 2945863
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Human B cell growth factor enhances proliferation and glial fibrillary acidic protein gene expression in rat astrocytes.
    Benveniste EN, Whitaker JN, Gibbs DA, Sparacio SM, Butler JL.
    Int Immunol; 1989 Nov 15; 1(3):219-28. PubMed ID: 2487687
    [Abstract] [Full Text] [Related]

  • 29. Immortalization of BGDF (BCGF II)- and BCDF-producing T cells by human T cell leukemia virus (HTLV) and characterization of human BGDF (BCGF II).
    Shimizu K, Hirano T, Ishibashi K, Nakano N, Taga T, Sugamura K, Yamamura Y, Kishimoto T.
    J Immunol; 1985 Mar 15; 134(3):1728-33. PubMed ID: 2981920
    [Abstract] [Full Text] [Related]

  • 30. T cell-derived B cell growth and differentiation factors. Dichotomy between the responsiveness of B cells from adult and neonatal mice.
    Pure E, Isakson PC, Kappler JW, Marrack P, Krammer PH, Vitetta ES.
    J Exp Med; 1983 Feb 01; 157(2):600-12. PubMed ID: 6600488
    [Abstract] [Full Text] [Related]

  • 31. Analysis of the B-cell growth-promoting activity of human IL-4, the co-stimulatory assay with anti-immunoglobulin antibodies. Comparison with the B-cell growth-promoting activity of other lymphokines.
    Almerigogna F, Giudizi MG, Biagiotti R, Alessi A, Defrance T, Banchereau J, Ricci M, Romagnani S.
    Immunology; 1989 Jun 01; 67(2):244-50. PubMed ID: 2502497
    [Abstract] [Full Text] [Related]

  • 32. Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.
    Muraguchi A, Butler JL, Kehrl JH, Fauci AS.
    J Exp Med; 1983 Feb 01; 157(2):530-46. PubMed ID: 6401797
    [Abstract] [Full Text] [Related]

  • 33. Modulation of IL-2-induced human B cell proliferation in the presence of human 50-kDa B cell growth factor and IL-4.
    Vazquez A, Mills S, Maizel A.
    J Immunol; 1989 Jan 01; 142(1):94-9. PubMed ID: 2783328
    [Abstract] [Full Text] [Related]

  • 34. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
    Hivroz C, Grillot-Courvalin C, Brouet JC, Seligmann M.
    Eur J Immunol; 1986 Aug 01; 16(8):1001-4. PubMed ID: 3488907
    [Abstract] [Full Text] [Related]

  • 35. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
    Jelinek DF, Lipsky PE.
    J Immunol; 1987 Aug 15; 139(4):1005-13. PubMed ID: 3112218
    [Abstract] [Full Text] [Related]

  • 36. Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
    Procopio AD, Allavena P, Ortaldo JR.
    J Immunol; 1985 Nov 15; 135(5):3264-71. PubMed ID: 3876382
    [Abstract] [Full Text] [Related]

  • 37. Distinction of B cell maturation factors from lymphokines affecting B cell growth and viability.
    Sherris DI, Sidman CL.
    J Immunol; 1986 Feb 01; 136(3):994-8. PubMed ID: 3079808
    [Abstract] [Full Text] [Related]

  • 38. Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor.
    Gordon J, Webb AJ, Walker L, Guy GR, Rowe M.
    Eur J Immunol; 1986 Dec 01; 16(12):1627-30. PubMed ID: 3028819
    [Abstract] [Full Text] [Related]

  • 39. Regulation of B cell activation and differentiation with factors generated by human T cell hybridomas.
    Mayer L, Fu SM, Kunkel HG.
    Immunol Rev; 1984 Apr 01; 78():119-35. PubMed ID: 6234220
    [Abstract] [Full Text] [Related]

  • 40. A B cell growth factor-like activity is secreted by cloned, neoplastic B cells.
    Brooks KH, Uhr JW, Vitetta ES.
    J Immunol; 1984 Dec 01; 133(6):3133-7. PubMed ID: 6333454
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.